Tag: Development Velocity

Clinical drug development expert brings 35 years of experience to SciMar’s mission to accelerate life-changing drugs to market ALLENTOWN, NJ, July 14, 2023 – SciMar ONE, Inc. (SciMar) welcomes Marco Taglietti, MD, to its Board of Advisors.  Marco is a 35-year pharmaceutical industry veteran whose career spans various clinical and executive roles with Fortune 500 and […]

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using the same antiquated, manual processes to move those life-changing therapies toward commercialization.

By Donna Conroy, MS, published in Clinical Researcher

Development Velocity is the speed a pharmaceutical company moves a therapy through the development process and into the market.